PrEP support program for gay and bisexual men
Part of Infections clinical trials.
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were assigned male at birth and have had sex with a man at least once.
- You tested negative for HIV before joining.
- You have never taken PrEP before.
- You are interested in trying PrEP and willing to attend follow-up visits.
- You have had at least one of these in the past 6 months: sex without a condom, shared needles for drugs, sex with an HIV-positive partner, a new sexually transmitted infection, used emergency HIV prevention (PEP) more than once, or you think you need PrEP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
This study tests two ways to help men who were assigned male at birth and use methamphetamine stay motivated to start PrEP, a medicine that prevents HIV. You may join if you are HIV-negative or don't know your status and haven't taken PrEP recently.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.